A new look at the medical management of infertility

Urologic Clinics of North America

Volumn 29, Issue 4, 2002, Pages 949-963

  Siddiq, Farjaad M ^a   Sigman, Mark ^a,b  

^a BROWN UNIVERSITY   (United States)

^b PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ANDROGEN; ANTIESTROGEN; AROMATASE INHIBITOR; BROMOCRIPTINE; CARNITINE; CLOMIFENE; ESTRADIOL; EXEMESTANE; FOLLITROPIN; GONADORELIN; HUMAN MENOPAUSAL GONADOTROPIN; KALLIKREIN; LETROZOLE; LEVACECARNINE; MESTEROLONE; PENTOXIFYLLINE; PLACEBO; PROSTAGLANDIN SYNTHASE INHIBITOR; SEX HORMONE BINDING GLOBULIN; TAMOXIFEN; TESTOLACTONE; TESTOSTERONE;

DIET SUPPLEMENTATION; DRUG EFFECT; FEMALE INFERTILITY; HORMONAL REGULATION; HORMONE DEFICIENCY; HUMAN; HYPERPROLACTINEMIA; HYPOGONADOTROPIC HYPOGONADISM; INFERTILITY THERAPY; MALE INFERTILITY; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; REVIEW; SPERMATOGENESIS; SPERMATOZOON MATURATION;

FERTILITY AGENTS, MALE; HUMANS; INFERTILITY, MALE; MALE;

EID: 0036865838     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(02)00085-X     Document Type: Review

References (144)

1. Greenberg S, Lipshultz L, Wein A. Experience with 425 subfertile male patients. J Urol 1978;119:501.
2. Hoffman AR, Crowley Jr WF. Induction of puberty in men by long-term pulsatile administration of low-dose gonadotropin releasing hormone. N Engl J Med 1982;307:1237.
3. Gilbaugh JH III, Lipshultz LI. Nonsurgical treatment of male infertility. Urol Clin North Am 1994;21:531.
4. Finkel DM, Phillips JL, Snyder PJ. Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. N Engl J Med 1985;313:651.
5. Sherins R. Evaluation and Management of Men with Hypogonadotropic Hypogonadism. Philadelphia: BC Decker; 1984.
6. Burris AS, Clark RV, Vantman DJ, et al. A low sperm concentration does not preclude fertility in men with isolated hypogonadotropic hypogonadism after gonadotropin therapy. Fertil Steril 1988;50:343.
7. Berezin M, Weissenberg R, Rabinovitch O, et al. Successful GnRH treatment in a patient with Kallmann's syndrome, who previously failed HMG/HCG treatment. Andrologia 1988;20:285.
8. Blumenfeld Z, Makler A, Frisch L, et al. Induction of spermatogenesis and fertility in hypogonadotropic azoospermic men by intravenous pulsatile gonadotropin-releasing hormone (GnRH). Gynecol Endocrinol 1988;2:151.
9. Liu L, Banks SM, Barnes KM, et al. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1988;67:1140.
10. Faiman C, Hoffman DL, Ryan RJ, et al. The "fertile eunuch" syndrome: Demonstration of isolated luteinizing hormone deficiency by radioimmunoassay technique. May Clin Proc 1968;43:661.
11. Al Ansari AA, Khalil TH, Kelani Y, et al. Isolated follicle-stimulating hormone deficiency in men: Successful long-term gonadotropin therapy. Fertil Steril 1984;42:618.
12. Dubin L, Amelar R. Etiologic factors in 1294 consecutive cases of male infertility. Fertil Steril 1971;22:489.
13. Aruldhes M, Valivullah H, Govindarajulu P. Specific effect of the thyroid on testicular enzymes involved in carbohydrate metabolism. I. Hypothyroidism. Int J Androl 1982;5:196.
14. Del-Rio AG, Blanco AM, Pignataro O, et al. High-affinity binding of T3 to epididymis nuclei. Arch Androl 2000;44:187.
15. Trummer H, Ramschak-Schwarzer S, Haas J, et al. Thyroid hormones and thyroid antibodies in infertile males. Fertil Steril 2001;76:254.
16. Augarten A, Weissenberg R, Pariente C, et al. Reversible male infertility in late onset congenital adrenal hyperplasia. J Endocrinol Invest 1991;14:237.
17. Jarow JP, Kirkland J, Koritnik DR, et al. Effect of obesity and infertility status on sex steroid levels in men. Urology 1993;42:171.
18. Molitch ME. Advances in pituitary tumor therapy: Medical treatment of prolactinomas. Endocrinol Metab Clin North Am 1999;28:143.
19. Mancini A, Guitelman A, Levalle O, et al. Bromocriptine in the management of infertile men after surgery of prolactin secreting adenoma. J Androl 1984;5:294.
20. Verhelst J. Cabergoline in the treatment of hyperprolactinemia: A study in 455 patients. J Clin Endocrinol Metab 1999;84:2518.
21. Collins JA, Wrixon W, Janes LB, et al. Treatmentindependent pregnancy among infertile couples. N Engl J Med 1983;309:1201.
22. Gerris J, Comhaire F, Hellemans P, et al. Placebocontrolled trial of high-dose mesterolone treatment of idiopathic male infertility. Fertil Steril 1991;55:603.
23. Knuth U, Honigl W, Bals-Pratsch M, et al. Treatment of severe oligospermia with human chorionic gonadotropin/human menopausal gonadotropin: A placebo-controlled, double-blind trial. J Clin Endocrinol Metab 1987;65:1081.
24. Sokol RZ, Steiner BS, Bustillo M, et al. A controlled comparison of the efficacy of clomiphene citrate in male infertility. Fertil Steril 1988;49:685.
25. Howards SS. Treatment of male infertility. N Engl J Med 1995;332:312.
26. Kamischke A, Nieschlag E. Analysis of medical treatment of male infertility. Hum Reprod 1999;14(Suppl 1):1.
27. O'Donovan P, Vandekerckhove P, Lilford R, et al. Treatment of male infertility: Is it effective? Review and meta-analysis of published randomized controlled trials. Hum Reprod 1993;8:1209.
28. Jackaman F, Ansell I, Ghanadian R, et al. The hormonal response to a synthetic androgen (mesterolone) in oligospermia. Clin Endocrinol 1977;6:339.
29. Nikannen V. The effects of mesterolone on the male accessory sex organs, on spermiogram, plasma testosterone, and FSH. Andrologia 1977;10:299.
30. Schellen T, Beck J. The influence of high doses of mesterolone on the spermiogram. Fertil Steril 1972;23:712.
31. Szollosi J, Falkay G, Sas M. Mesterolone treatment of patients with pathospermia. Int Urol Nephrol 1978;10:251.
32. Aafjes J, VanDer Vijer J, Brugman F. Double blind cross-over treatment with mesterolone and placebo of subfertile men: Value of testicular biopsy. Andrologia 1983;15:531.
33. Comhaire F. Treatment of idiopathic testicular failure with high-dose testosterone undecanoate: A double-blind pilot study. Fertil Steril 1990;54:689.
34. Comhaire F, Schoonjans F, Abdelmassih R, et al. Does treatment with testosterone undecanoate improve the in-vitro fertilizing capacity of spermatozoa in patients with idiopathic testicular failure. Hum Reprod 1995;10:2600.
35. Gregoriou O, Papadias C, Gargaropoulos A, et al. Treatment of idiopathic infertility with testosterone undecanoate: A double-blind study. Clin Exp Obstet Gynecol 1993;20:9.
36. Mauss J. Ergebnisse der behandlung von fertilitatsstorungen des mannes mit mesterolon oder einem placebo. Arzneimittelforschung 1974;24:1338.
37. Pusch H. Oral treatment of oligospermia with testosterone undecanoate: Results of a double blind study. Arch Androl 1989;2:479.
38. Scottish Infertility Group (SIG). Randomized trial of mesterolone versus vitamin C for male infertility. Br J Urol 1984;56:740.
39. World Health Organization Task Force on the Diagnosis and Treatment of Infertility. Mesterolone and idiopathic male infertility: A doubleblind study. Int J Androl 1989;12:254.
40. Heller C, Nelson W, Hill I, et al. Improvement in spermatogenesis following depression of the human testis with testosterone. Fertil Steril 1950;1:415.
41. Sigman M, Vance ML. Medical treatment of idiopathic infertility. Urol Clin North Am 1977;14:459.
42. Rowley MJ, Heller CG. The testosterone rebound phenomenon in the treatment of male infertility. Fertil Steril 1972;23:498.
43. Charny CW, Gordon JA. Testosterone rebound therapy: A neglected modality. Fertil Steril 1978;29:64.
44. Amelar R, Dubin L. The management of idiopathic male infertility. J Reprod Med 1977;18:191.
45. Wang C, Chan C, Wong K, et al. Comparison of the effectiveness of placebo, clomiphene citrate, mesterolone, pentoxifylline, and testosterone rebound therapy for the treatment of idiopathic oligospermia. Fertil Steril 1983;40:358.
46. Chehval MJ, Mehan DJ. Chorionic gonadotropins in the treatment of the subfertile male. Fertil Steril 1979;31:666.
47. Homonnai ZT, Peled M, Paz GF. Changes in semen quality and fertility in response to endocrine treatment of subfertile men. Gynecol Obstet Invest 1978;9:244.
48. Margolioth EJ, Laufer N, Persistz E, et al. Treatment of oligoasthenospermia with human chorionic gonadotropin: Hormonal profiles and results. Fertil Steril 1983;39:841.
49. Pusch H, Purstner P, Haas J. Treatment of asthenozoospermia with HCG. Andrologia 1986;18:201.
50. Bodner DR. Critical review of pharmacologic therapies. Semin Reprod Endocrinol 1988;6:377.
51. Schill W, Jungst D, Unterburger P, et al. Combined HMG/HCG treatment in subfertile men with idiopathic normogonadotropic oligozoospermia. Int J Androl 1982;5:467.
52. Schill W. Medical treatment of male infertility. In: Insler V, Lunenfeld B, editors. Infertility: Male and Female. Edinburgh: Churchill Livingstone; 1986. p. 533.
53. Foresta C, Betella A, Merico M, et al. Use of recombinant human follicle-stimulating hormone in the treatment of male factor infertility. Fertil Steril 2002;77:238.
54. Comodo F, Vargiu N, Farina M, et al. Double-Blind FSH-HP/Placebo Treatment of Severe Male Factor Related Infertility: Effect on Sperm Parameters and IVF/ICSI Outcome [Poster]. European Society of Human Reproduction and Embryology. Maastricht, The Netherlands, June 30-July 3, 1996. p. S41.
55. Kamischke A, Behre HM, Bergmann M, et al. Recombinant human FSH for treatment of male idiopathic infertility: A randomized, double-blind, placebo-controlled, clinical trial. Hum Reprod 1998;13:596.
56. Matorras R, Perez C, Corcostegui B, et al. Treatment of the male with follicle-stimulating hormone in intrauterine insemination with husband's spermatozoa: A randomized study. Hum Reprod 1997;12:24.
57. Aparicio N, Schwarzstein L, Turner E, et al. Treatment of idiopathic normogonadotropic oligoasthenospermia with synthetic luteinizing hormone-releasing hormone. Fertil Steril 1976;27:549.
58. Badenoch DF, Waxman J, Boorman L, et al. Administration of a gonadotropin releasing hormone analogue in oligospermic infertile males. Acta Endocrinol (Copenh) 1988;117:265.
59. Fauser BCJM, Rolland R, Dony JM, et al. Longterm, pulsatile, low-dose, subcutaneous luteinizing hormone-releasing hormone administration in men with idiopathic oligozoospermia: Failure of therapeutic and hormonal response. Andrologia 1985;17:143.
60. Shwarzstein L, Aparicio MJ, Turner D, et al. Use of synthetic luteinizing hormone-releasing hormone in treatment of oligospermic men: A preliminary report. Fertil Steril 1975;26:331.
61. Shwarzstein L, Aparicio N, Schally A. D-Tryptophan-6-luteinizing hormone-releasing hormone in the treatment of normogonadotropic oligozoospermia. Int J Androl 1982;5:171.
62. Zarate A, Valdes-Vallina F, Gonzalez A, et al. Therapeutic effect of synthetic LHRH in male infertility due to idiopathic azoospermia and oligospermia. Fertil Steril 1973;24:485.
63. Wagner ROF, Warsch F. Pulsatile LHRH therapy of 'slow pulsing oligospermia': Indirect evidence for a hypothalamic origin of the disorder. Acta Endocrinol 1984;105(Suppl 264):142.
64. Bals-Pratsch M, Knuth U, Honigl W, et al. Pulsatile GnRH-therapy in oligozoospermic men does not improve seminal parameters despite decreased FSH levels. Clin Endocrinol (Oxf) 1989;30:549.
65. Aulitzky W, Frick J, Hadziselimovic F. Pulsatile LHRH therapy in patients with oligozoospermia and disturbed LH pulsatility. Int J Androl 1989;12:265.
66. Crottaz B, Senn A, Reymond MJ, et al. Folliclestimulating hormone bioactivity in idiopathic normogonadotropic oligoasthenozoospermia: Double-blind trial with gonadotropin-releasing hormone. Fertil Steril 1992;57:1034.
67. Heller CG, Rowley MJ, Heller GV. Clomiphene citrate: A correlation of its effects on sperm concentration and morphology, total gonadotropins, ICSH, estrogen and testosterone excretion and testicular cytology in normal men. J Clin Endocrinol 1969;29:638.
68. Jungck E, Roy S, Greenblatt R, et al. Effect of clomiphene citrate on spermatogenesis in the human: A preliminary report. Fertil Steril 1964;15:40.
69. Mellinger R, Thompson R. Effect of clomiphene citrate in male infertility. Fertil Steril 1966;17:94.
70. Foss G, Tindall V, Birkett J. The treatment of subfertile men with clomiphene citrate. J Reprod Fertil 1973;32:167.
71. Paulson D. Cortisone acetate versus clomiphene citrate in pregerminal idiopathic oligospermia. J Urol 1979;121:432.
72. Ronnberg L. The effect of clomiphene citrate on different sperm parameters and serum hormone levels in preselected infertile men: A controlled double-blind crossover study. Int J Androl 1980;3:479.
73. Scottish Infertility Group (SIG). The effect of clomiphene citrate and vitamin C for male infertility. Br J Urol 1982;54:780.
74. World Health Organization. A double-blind trial of clomiphene citrate for the treatment of idiopathic male infertility. Int J Androl 1992;15:299.
75. Check JH, Chase JS, Nowroozi K, et al. Empirical therapy of the male with clomiphene in couples with unexplained infertility. Int J Fertil 1989;34:120.
76. Micic S, Dotlic R. Evaluation of sperm parameters in clinical trial with clomiphene citrate of oligospermic men. J Urol 1985;133:221.
77. Bartsch G, Scheiber K. Tamoxifen treatment in oligospermia. Eur Urol 1981;7:283.
78. Buvat J, Ardaens K, Lemaire A, et al. Increased sperm counts in 25 cases of idiopathic normogonadotropic oligospermia following treatment with tamoxifen. Fertil Steril 1983;39:700.
79. Comhaire F. Treatment of oligospermia with tamoxifen. Int J Fertil 1976;21:232.
80. Vermeulen A, Comhaire F. Hormonal effects of an antiestrogen, tamoxifen, in normal and oligospermic men. Fertil Steril 1978;29:320.
81. Ainmelk Y, Belisle S, Carmel M, et al. Tamoxifen citrate therapy in male infertility. Fertil Steril 1987;48:113.
82. Krause W, Holland-Moritz H, Schramm P. Treatment of idiopathic oligozoospermia with tamoxifen: A randomized controlled study. Int J Androl 1992;15:14.
83. Torok L. Treatment of oligozoospermia with tamoxifen (open and controlled studies). Andrologia 1985;17:497.
84. Willis K, London D, Bevis M, et al. Hormonal effects of tamoxifen in oligospermic men. J Endocrinol 1977;73:171.
85. Paulson D. Clomiphene citrate in the management of male hypofertility: Predictors for treatment selection. Fertil Steril 1977;28:1226.
86. Coffey D, Rajfer J. Urologic Endocrinology. Philadelphia: WB Saunders; 1986. p. 170.
87. Inkster S, Yue W, Brodie A. Human testicular aromatase immunocytochemical and biochemical studies. J Endocrinol Metab 1995;80:1941.
88. Kulin HE, Reiter EO. Gonadotropin suppression by low dose estrogen in men: Evidence for differential effects upon FSH and LH. J Clin Endocrinol Metab 1972;35:836.
89. Veldhuis JD, Sowers JR, Rogol AD, et al. Pathophysiology of male hypogonadism associated with endogenous hyperestrogenism: Evidence for dual defects in the gonadal axis. N Engl J Med 1985;312:1371.
90. Ciaccio LA, Joseph AA, Kinel FA. Direct inhibition of testicular function in rats by estriol and progesterone. J Steroid Biochem 1978;9:1257.
91. Onoda M, Hall PF. Inhibition of testicular microsomal cytochrome P-450 (17alpha-hydroxylase/C17, 20-lyase) by estrogens. Endocrinology 1981;109:763.
92. Vigersky RA, Glass AR. Effects of delta-1testolactone on the pituitary-testicular axis in oligospermic men. J Clin Endocrinol Metab 1981;52:897.
93. Dony JM, Smals AG, Rolland R, et al. Effect of chronic aromatase inhibition by delta-1-testolactone on the pituitary-gonadal function in oligozoospermic men. Andrologia 1986;18:69.
94. Clark R, Sherins R. Treatment of men with idiopathic oligozoospermic infertility using the aromatase inhibitor, testolactone: Results of a double-blinded, randomized, placebo-controlled trial with cross over. J Androl 1989;10:240.
95. Pavlovich CP, Goldstein M, Schlegel PN. Testicular Failure is Associated with a Medically Treatable Endocrinopathy [Abstract O-017]. European Society of Human Reproduction and Embryology, Goteborg, Sweden, June 21-24, 1998.
96. Pavlovich CP, King P, Goldstein M, et al. Evidence of a treatable endocrinopathy in infertile men. J Urol 2001;165:837.
97. Raman JD, Schlegel PN. Aromatase inhibitors for male infertility. J Urol 2002;167:624.
98. Palm S, Schill W, Wallner O, et al. Occurrence of components of the kallikrein-kinin system in human genital secretions and their possible function in stimulation of sperm motility and migration. In: Sicuter F, Back N, Haberland G, editors. Kinins: Pharmacodynamics and Biological Roles. New York: Plenum Press; 1976. p. 271.
99. Schill W. Treatment of idiopathic oligozoospermia by kallikrein: Results of a double-blind study. Arch Androl 1979;2:163.
100. Bedford N, Elstein M. The effect of kallikrein on male infertility: A double blind study. In: Insler V, Bettendorf G, editors. Diagnosis and Treatment of Infertility. Amsterdam: Elsevier; 1981. p. 339.
101. Izzo P, Canale D, Bianchi B, et al. The treatment of male subfertility with kallikrein. Andrologia 1984;16:156.
102. Keck C, Behre HM, Jockenhovel F, et al. Ineffectiveness of kallikrein in treatment of idiopathic male infertility: A double-blind, randomized, placebo-controlled trial. Hum Reprod 1994;9:325.
103. Saidi K, Wenn R, Sharif F. Bromocriptine for male infertility. Lancet 1977;1:250.
104. Segal S, Polishuk W, Ben-David M. Hyperprolactinemic male infertility. Fertil Steril 1976;27:1425.
105. Ainmelk Y, Belisle S, Kandlaft N, et al. Bromocriptine therapy in oligozoospermic men. Arch Androl 1982;8:135.
106. Glatthaar C, Donald R, Smith R, et al. Pituitary function in normoprolactinemic infertile men receiving bromocriptine. Clin Endocrinol 1980;13:455.
107. Hovatta O, Koskimies I, Ranta T, et al. Bromocriptine treatment of oligozoospermia: A double blind study. Clin Endocrinol 1979;13:455.
108. Aparicio N, Schwarzstein L, Turner E, et al. Pentoxifylline (BL 191) by oral administration in the treatment of asthenozoospermia. Andrologia 1980;12:228.
109. Marrama P, Baraghini G, Carani C, et al. Further studies on the effects of pentoxifylline on sperm count and sperm motility in patients with idiopathic oligoasthenozoospermia. Andrologia 1985;17:612.
110. Micic S, Hadzi-Djokic J, Dotlic R. Pentoxifylline treatment of oligoasthenospermic men. Acta Eur Fertil 1988;19:135.
111. Jeulin C, Lewin LM. Role of free L-carnitine and acetyl-L-carnitine in post-gonadal maturation of mammalian spermatozoa. Hum Reprod Update 1996;2:87.
112. Jeulin C, Soufir JC, Marson J, et al. Acetylcarnitine and spermatozoa: Relationship with epididymal maturation and motility in the boar and men. Reprod Nutr Dev 1988;28:1317.
113. Jeulin C, Soufir JC, Jouannet P. Effects of Lcarnitine and DL-acetylcarnitine on human sperm motility as measured by laser Doppler velocimetry. IRCS Medical Science 1981;9:722.
114. Tanphaichitr N. In vitro stimulation of human sperm motility by acetylcarnitine. Int J Fertil 1977;22:85.
115. Kohengkul S, Tanphaichitr V, Muangnum V, et al. Levels of L-carnitine and L-O-acetylcarnitine in normal and infertile human semen. Fertil Steril 1977;28:1333.
116. Matalliotakis I. L-carnitine levels in the seminal plasma of fertile and infertile men: Correlation with sperm quality. Int J Fertil Womens Med 2000;45:236.
117. Menchini-Fabris GF, Canale D, Izzo PL, et al. Free L-carnitine in human semen: Its variability in different andrologic pathologies. Fertil Steril 1984;42:263.
118. Saeed S. Biochemical parameters in evaluation of oligospermia. Journal of the Pakistan Medical Association 1994;44:137.
119. Soufir JC, Doucot B, Marson J, et al. Levels of seminal free carnitine in fertile and infertile man. Int J Androl 1984;7:188.
120. Zopfgen A, Priem F, Sudhoff F, et al. Relationship between semen quality and the seminal plasma components carnitine, alpha-glucosidase, fructose, citrate and granulocyte elastase on infertile men compared with a normal population. Hum Reprod 2000;15:840.
121. Bartellini M, Canale D, Izzo PL, et al. L-carnitine and acetyl carnitine in human sperm with normal and reduced motility. Acta Eur Fertil 1987;18:29.
122. Costa M, Canale D, Filicori MD, et al. L-carnitine in idiopathic asthenozoospermia: A multicenter study. Andrologia 1994;26:155.
123. Micic S, Mladenovic I, Genbacev O. Does L-carnitine administered in vivo improve sperm motility? Arch Androl 1995;7:127.
124. Micic S. Effects of L-carnitine on sperm motility and number in infertile men. Presented at the 16th World Congress on Fertility and Sterility. San Francisco, CA. October 4-9, 1998.
125. Muller-Tyl E, Lohninger A, Fischl F, et al. Effects of carnitine on sperm count and motility. Fertilitat 1988;4:1.
126. Vitali G, Parente R, Melotti C. Carnitine supplementation in human idiopathic asthenospermia: Clinical results. Drugs Exp Clin Res 1995;21:157.
127. Campaniello E, Petrarolo N, Meriggiola MC, et al. Carnitine administration in asthenospermia [abstract]. Presented at the IV International Congress on Andrology. Florence, Italy, May 14-18, 1989. p. 14.
128. Loumbakis P, Anezinis P, Evangeliou A, et al. Effect of L-carnitine in patients with asthenospermia [abstract 954]. Eur Urol 1996;30(Suppl 2):255.
129. Moncada ML, Vicari E, Cimino C, et al. Effect of acetylcarnitine treatment in oligoasthenospermic patients. Acta Eur Fertil 1992;23:221.
130. Barkay J, Harpaz-Kerpel S, Ben-Ezra S, et al. The prostaglandin inhibitor effect of anti-inflammatory drugs in the therapy of male infertility. Fertil Steril 1984;42:406.
131. Gottlieb C, Bygdeman M. Prostanoids in sperm function. Prostaglandins Leukot Essent Fatty Acids 1988;34:205.
132. Hayashi S, Noda Y, Mori T. Analysis of the role of prostaglandins in the fertilization process. Eur J Obstet Gynecol Reprod Biol 1988;29:287.
133. Roy AC, Ratnam SS. Biosynthesis of prostaglandins by human spermatozoa in vitro and their role in acrosome reaction and fertilization. Mol Reprod Dev 1992;33:303.
134. Escalier D. Impact of genetic engineering on the understanding of spermatogenesis. Hum Reprod Update 2001;7:191.
135. Brinster RL, Zimmerman JW. Spermatogenesis following male germ cell transplantation. Proc Natl Acad Sci USA 1994;91:11289.
136. Eddy E, Washburn T, Bunch D, et al. Targeted disruption of the estrogen receptor gene in male mice caused alteration of spermatogenesis and infertility. Endocrinology 1993;137:4796.
137. Krege J, Hodgin J, Couse J, et al. Generation and reproductive phenyl types of mice lacking estrogen receptor beta. Proc Natl Acad Sci USA 1998;95:15677.
138. Mahato D, Goulding EH, Korach KS, et al. Spermatogenic cells do not require estrogen receptor alpha for development of function. Endocrinology 2000;141:1273.
139. Smith EP, Boyd J, Frank JR, et al. Estrogen resistance caused by a mutation in the estrogen receptor gene in a man. N Engl J Med 1994;331:1056.
140. Aitken ML. A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease. Hum Gene Ther 2001;12:1907.
141. Gomella LG. Phase I study of intravesical vaccinia virus as a vector for gene therapy of bladder cancer. J Urol 2001;166:1291.
142. Hasenburg A. Adenovirus mediated thymidine kinase gene therapy in combination with topotecan for patients with recurrent ovarian cancer: 2.5-Year follow-up. Gynecol Oncol 2001;83:549.
143. MacGregor RR. Clinical protocol: A phase I openlabel clinical trial of the safety and tolerability of single escalating doses of autologous CD4 T cells transduced with VRX496 in HIV-positive subjects. Hum Gene Ther 2001;12:2028.
144. Nagano M, Shinohara T, Abarbock MR, et al. Retrovirus mediated gene delivery into male germ line stem cells. FEBS Lett 2000;475:7.